Alpine Global Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $701K | Buy |
|
|||||
|
2025
Q1 | $549K | Sell |
|
|||||
|
2024
Q4 | $1.08M | Buy |
|
|||||
|
2024
Q3 | $456K | Sell |
|
|||||
|
2024
Q2 | $675K | Hold |
|
|||||
|
2024
Q1 | $663K | Buy |
|
|||||
|
2023
Q4 | $635K | Sell |
|
|||||
|
2023
Q3 | $558K | Buy |
|
|||||
|
2023
Q2 | $590K | Sell |
|
|||||
|
2023
Q1 | $652K | Hold |
|
|||||
|
2022
Q4 | $532K | Hold |
|
|||||
|
2022
Q3 | $624K | Buy |
|
|||||
|
2022
Q2 | $539K | Buy |
|
|||||
|
2022
Q1 | $810 | Buy |
|
|||||
|
2021
Q4 | $864K | Sell |
|
|||||
|
2021
Q3 | $907K | Buy |
|
|||||
|
2021
Q2 | $1.44M | Sell |
|
|||||
|
2021
Q1 | $1.92M | Buy |
|
|||||
|
2020
Q4 | $1.72M | Sell |
|
|||||
|
2020
Q3 | $3.28M | Sell |
|
|||||
|
2020
Q2 | $2.66M | Buy |
|
|||||
|
2020
Q1 | $985K | Buy |
|